Heartflow (HTFL) Amortization of Deferred Charges (2024 - 2025)

Heartflow's (HTFL) quarterly Amortization of Deferred Charges came in at -$2.2 million in Q4 2025, down 426.89% year-on-year from $683417.0 in Q4 2024, and down 239.45% quarter-over-quarter from $1.6 million in Q3 2025.

Heartflow (HTFL) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends

Heartflow's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at -$2.2 million for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges fell 426.89% year-over-year to -$2.2 million in Q4 2025; TTM through Dec 2025 was -$372000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $3.1 million, up 94.72% from the prior year.
  • Amortization of Deferred Charges eased to -$2.2 million in Q4 2025 per HTFL's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $1.6 million in Q3 2025 and bottomed at -$2.2 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.73 Bn -
10 Heartflow 906.97 Mn 730.19 Mn 39.06 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.23 Mn
Dec 31, 2025 -2.23 Mn
Sep 30, 2025 1.60 Mn
Sep 30, 2025 1.60 Mn
Dec 31, 2024 -424,000.00
Dec 31, 2024 -424,000.00
Sep 30, 2024 684,000.00
Sep 30, 2024 684,000.00